FDA Clearance Tracker · K242776
LimFlow V-Ceiver
Last checked: Nov 19, 2026Latest source record: Feb 14, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Feb 14, 2025
Substantially Equivalent
Time to decision
154 days
Received Sep 13, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K242776
- Device name
- LimFlow V-Ceiver
- Applicant
- LimFlow, Inc.
- Applicant location
- Irvine, CA
- Received
- Sep 13, 2024
- Decided
- Feb 14, 2025
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Device, Percutaneous Retrieval (MMX)
- Device class
- Class II
- Regulation
- 21 CFR 870.5150
- Specialty
- CardiologyInterventional Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MMX. The earliest in FDA's data is K014109, decided Mar 12, 2002.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K242776
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for LimFlow, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- LimFlow Vector510(k)
K260188 · Decided Mar 18, 2026 · 55 days after receipt
Device type: Valvulotome (MGZ) · Cardiology
- LimFlow ARC510(k)
K251376 · Decided May 31, 2025 · 29 days after receipt
Device type: Catheter For Crossing Total Occlusions (PDU) · Cardiology
- LimFlow SystemBreakthroughPMA
P220025 · Decided Sep 11, 2023 · 315 days after receipt
Device type: Stent graft, infrapopliteal, venous arterialization (QWN) · Cardiology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.